The North America Artificial Intelligence In Precision Medicine Market would witness market growth of 31.7% CAGR during the forecast period (2022-2028).
The market is growing as a consequence of increased elderly populations, rapid technological breakthroughs in healthcare, and rising respiratory illness rates. The sector will rise in part due to the rising popularity of therapeutic respiratory devices such as oxygen concentrators, nebulizers, and humidifiers.
The respiratory segment is anticipated to develop as respiratory conditions, including sleep apnea and chronic obstructive pulmonary disease, become more common. 3.23 million people worldwide will pass away in 2019 from moderate and severe chronic obstructive pulmonary diseases, according to WHO forecasts (COPD).
Major corporations are using partnerships and collaborations more frequently as a means of preserving their market position. For instance, Intel and the Perelman School of Medicine at the University of Pennsylvania worked together to develop an AI model that aids in the early diagnosis of brain tumors.
Demand for the market in the United States is anticipated to be driven by the high adoption rate of AI technologies throughout healthcare and pharma, the substantial presence of leading AI software and system suppliers, and the merged investment by government and private organizations in the improvement and growth of research and development activities. The nation's strong infrastructure, which can accommodate cutting-edge medical solutions, is likely to help it eventually take the lead in the regional market.
The US market dominated the North America Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,549.5 Million by 2028.The Canada market is poised to grow at a CAGR of 34.7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 33.5% during (2022 - 2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Artificial Intelligence In Precision Medicine Market is Predict to reach $6.3 Billion by 2028, at a CAGR of 32.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
By Application
By Component
By Technology
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 